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Abstract 
Background: Central venous catheters (CVC) are important intravenous routes, that nowadays they can be used 
for various reasons including resuscitation management, intravenous feeding, chemotherapy drugs, and blood 
transfusions. Due to the special importance and increasing usage of these catheters lengthening the duration of 
these catheters are very important. Infections are the most common cause of removal of this catheter. 
Methods: In this prospective study (cohort), 80 patients with central venous catheter were divided into two 
groups. In the first group Vancomycin once per day injected inside catheter equal to their intraluminal volume 
and remained for 2 h, then catheter was aspirated and washed. But in control group catheter was washed only 
with normal saline. Finally, catheter infection rates in the two groups were compared. 
Results: In the group that used intraluminal Vancomycin, catheter infection was ‎observed in 3 cases and was 
confirmed by blood culture, but in none of them ‎catheter infection agent was not Gram-positive cocci.‎ In 
control group, 18 cases of catheter infection were confirmed by culture that in 16 cases were caused by Gram-
positive cocci that in 14 cases catheter was removed, and in 2 cases of catheter infection, infectious agent was 
Staphylococcus epidermidis which catheter maintained with appropriate antibiotics. 
Conclusions: Use of the intraluminal Vancomycin significantly reduces the rate of infection and thus increase 
the survival rate of CVC. 
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Introduction 
Central venous catheters (CVC) are inserted through an 
internal jugular vein or subclavian vein and tip of them 
is placed in the right atrium entrance (1-3). CVC are 
used for various purposes, including the resuscitation 
management and fluid therapy, especially in cases 
where other measures, such as urine or vital signs are 
not reliable or for injecting solutions with a high 
concentration such as glucose higher than 10% which 
injection of these solutions through peripheral veins 
cause phlebitis and venous damage (4,5). Furthermore, 
in patients who require long-term use of reliable 
intravenous lines, CVC can be used. 
Embedding CVC accompanied with important 
complications, among them include pneumothorax, 
cardiac arrhythmias, air embolism, and damage to 
adjacent artery (6-9). With regard to matters mentioned 
maintenance of central venous catheter is very 
important and should not be routinely replaced or 
removed. The most common cause for removal of this 
catheter is infections; these infections are an important 
factor in the morbidity and mortality of patients  
(10-13). Gram-positive organisms are responsible for 
most of central venous catheter-related infections, such 
that in 40-80% of cases is factor for Staphylococcus 
and other factors such as Enterococcus and Gram-
negative bacilli were seen in patients with weakened 
immune systems. Less cases are included (14-16). 
In similar studies about dialysis temporary catheters or 
dialysis catheter with cuff, considerably have been saved 
(17-19). According to the wider use of CVC Compared 
with dialysis catheters, we decided to investigate the effect 
of intraluminal antibiotics to increase survival and reduce 
morbidity and mortality in patients. 
 
Materials and Methods 
A prospective cohort study conducted during March- 
September 2012. In this study, 80 inpatients that were 
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received central venous catheter were selected from two 
hospitals (Shariati and Sina Hospitals) in Tehran, Iran. All 
catheters have a lumen and have been made by ARROW 
and all of them embedded through right subclavian 
because infection in internal jugular and subclavian 
venous catheter is different. All the patients had a catheter 
inserted for total parenteral nutrition (TPN). 
Patients by computer randomly divided into two 
groups of 40 patients each. In control group, patients 
without any intervention were observed, but in second 
group once daily equal volume of intraluminal catheter 
received intraluminal vancomycin and 2 hours after 
injection, CVC has not been used. 
During the study period, if patients experienced 
symptoms of sepsis syndrome, first probable infection 
sites such as urinary tract infection, pneumonia, 
surgical wound infections, and area of environmental 
catheter investigated and then after rejecting the other 
infection sites and doing the peripheral blood culture 
using content of sent catheter, catheter infection could 
be considered if microbial growth was similar. 
Since during the initial investigation for possible 
infection source blood culture has been sent. Therefore, 
if that growth staphylococcus epidermidis, without 
removing the catheter implanted catheter infection 
treated with antibiotics. Finally, the incidence of 
infection in the two groups was compared. Data and 
statistical analysis was performed using SPSS software 
(version 21.0, IBM Corporation, Armonk, NY, USA) 
and t-test was used for comparison of two groups.  
 
Results 
During the study, in group that ‎received intraluminal 
vancomycin ‎three cases of catheter infection proven by 
culture was observed. In all three cases, Gram-negative 
bacteria had grown, and the catheter was removed. 
In the control group, 18 cases of infection were 
observed (confirmed by blood cultures) that 16 of 
them, (8.88%) grown factor was Gram-positive cocci. 
In 14 cases, the catheter was removed and sent for 
cultivation, and the tip of the catheter infection was 
confirmed. In 2 other cases, since grown factor was 
Staphylococcus epidermidis addition to maintaining the 
catheter infection was cured by treatment AB. The 
average time to maintain the catheter in patients treated 
with intraluminal vancomycin was 28.7 days and in the 
second group was 13.1 days. 
 
Discussion 
In the present study which designed as a cohort study, 
80 patients were selected. To avoid the confounding 
effect of how to use of the catheters, in all cases, the 
purpose of Embedding central venous catheter was 
TPN. Considering that location of catheter effects on 
infection rate, and subclavian catheters have the 
lowest rates of infection, all patients had right 
subclavian catheter to remove the confounding 
variable. Due to the patients with immune deficiency 
system are more at risk of infection compared to 
normal patients. Selected patients, neither of them did 
not suffering from immune deficiency diseases and 
chronic diseases. CVC are made of different types 
and by different companies. In this study, to avoid 
confounding the catheters that coated with antibiotic 
were not used. Meanwhile, in all patients single 
lumen central venous catheter sets (14 Ga and length 
20 cm) were used, that produced by Arrow Company, 
diameter of catheters are 0.032 inch which is roughly 
equivalent 0.81 mm. Stick and length of used catheter 
were 18 Ga and 6.35 cm, respectively. Laboratory 
flow velocity of this catheter is 6900 cc/hour, and 
their intraluminal volume is 0.35 cc. 
Size of injected Vancomycin in catheter without 
any connections such as road and Etc. was 4 cc that 
this injection conducted by insulin syringe and 
intravenous vancomycin (Vancomycin 500 mg) made 
by Jaber Hayan Pharmaceutical Company was used 
which is the equivalent 40 mg of intraluminal volume. 
Of the study and after all these measures do 
significantly with P < 0.05 the rate of infection was 
lower in patients treated with intraluminal AB, and 
therefore the longevity of the catheters was also 
significantly higher, and also longevity of catheters 
significantly increased. 
As mentioned CVC are important, but because of 
its dangerous potential effects use of them is specific, 
and is exclusive to this catheter. Therefore, we would 
increase the duration of their consumption to fewer 
complications imposed on patients. Central venous 
catheter infections are the most common cause leading 
to the removal of central venous catheter. However, 
central venous catheter infections have dangerous 
complications and potentially fatal such as septic shock 
or sever sepsis, using a strategy that can reduce the rate 
of infection can be very beneficial in reducing 
morbidity and mortality (20). 
Use of intraluminal vancomycin as a strategy that 
was used in CVCs in this study showed that use of 
them can be helpful in reduce the infection rate and 
increase the longevity of CVC. 
As a conclusion, vancomycin can reduce central venous 
catheter infection. Furthermore, use of intraluminal 
Vancomycin can increase the duration of use CVC. 
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